![Steven Tuch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Tuch
Directeur de la Recherche - Actions chez
Mizuho Securities USA LLC
Profil
Mr. Steven Tuch is a Managing Director & Co-Head of Healthcare Equity Capital Markets at Mizuho Securities USA LLC.
Mr. Tuch was previously employed as a Chief Financial Officer & Executive Vice President by vTv Therapeutics, Inc. and a Head-Corporate Development by Rallybio Corp.
He received his undergraduate degree from the University of Michigan and an MBA from Stanford Graduate School of Business.
Postes actifs de Steven Tuch
| Sociétés | Poste | Début |
|---|---|---|
Mizuho Securities USA LLC
 Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Directeur de la Recherche - Actions | 01/03/2025 |
Anciens postes connus de Steven Tuch
| Sociétés | Poste | Fin |
|---|---|---|
| VTV THERAPEUTICS INC. | Directeur Financier/CFO | 21/03/2025 |
| RALLYBIO CORPORATION | Corporate Officer/Principal | 01/01/2022 |
Formation de Steven Tuch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Mizuho Securities USA LLC
Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vTv Therapeutics, Inc.
 vTv Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company which engages in discovery and development of orally administered small molecule drugs for treating metabolic and inflammatory disorders | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Choisissez Zonebourse 
